Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Steatosis in chronic hepatitis C: fuel for overproduction of oxidative stress?

Literature DB >> 16007406

Steatosis in chronic hepatitis C: fuel for overproduction of oxidative stress?

Kazuhiko Koike.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 16007406 DOI： 10.1007/s00535-005-1626-8

Source DB: PubMed Journal: J Gastroenterol ISSN： 0944-1174 Impact factor: 7.527

× No keyword cloud information.

19 in total

1. Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans.

Authors: K Moriya; T Todoroki; T Tsutsumi; H Fujie; Y Shintani; H Miyoshi; K Ishibashi; T Takayama; M Makuuchi; K Watanabe; T Miyamura; S Kimura; K Koike
Journal: Biochem Biophys Res Commun Date: 2001-03 Impact factor: 3.575

2. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis.

Authors: Akira Kitase; Keisuke Hino; Takakazu Furutani; Michiari Okuda; Toshikazu Gondo; Isao Hidaka; Yuichi Hara; Yuhki Yamaguchi; Kiwamu Okita
Journal: J Gastroenterol Date: 2005-06 Impact factor: 7.527

3. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.

Authors: V Paradis; P Mathurin; M Kollinger; F Imbert-Bismut; F Charlotte; A Piton; P Opolon; A Holstege; T Poynard; P Bedossa
Journal: J Clin Pathol Date: 1997-05 Impact factor: 3.411

Review 4. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer.

Authors: H Wiseman; B Halliwell
Journal: Biochem J Date: 1996-01-01 Impact factor: 3.857

Review 5. Oxy-radicals and cancer.

Authors: P A Cerutti
Journal: Lancet Date: 1994-09-24 Impact factor: 79.321

6. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis.

Authors: K Moriya; K Nakagawa; T Santa; Y Shintani; H Fujie; H Miyoshi; T Tsutsumi; T Miyazawa; K Ishibashi; T Horie; K Imai; T Todoroki; S Kimura; K Koike
Journal: Cancer Res Date: 2001-06-01 Impact factor: 12.701

7. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

Authors: Laetitia Fartoux; Olivier Chazouillères; Dominique Wendum; Raoul Poupon; Lawrence Serfaty
Journal: Hepatology Date: 2005-01 Impact factor: 17.425

Review 8. The ins and outs of mitochondrial dysfunction in NASH.

Authors: B Fromenty; M A Robin; A Igoudjil; A Mansouri; D Pessayre
Journal: Diabetes Metab Date: 2004-04 Impact factor: 6.041

9. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.

Authors: Heather M Patton; Keyur Patel; Cynthia Behling; David Bylund; Lawrence M Blatt; Marc Vallée; Shanon Heaton; Andrew Conrad; Paul J Pockros; John G McHutchison
Journal: J Hepatol Date: 2004-03 Impact factor: 25.083

10. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

Authors: L Castéra; C Hézode; F Roudot-Thoraval; A Bastie; E-S Zafrani; J-M Pawlotsky; D Dhumeaux
Journal: Gut Date: 2003-02 Impact factor: 23.059

3 in total